Alliance for Clinical Trials in Oncology Operations Center

肿瘤学临床试验联盟运营中心

• 批准号: 9910970
• 负责人: Monica M Bertagnolli
• 金额: $ 200万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-17 至 2025-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9910970
• 关键词: Address; Adolescent and Young Adult; Adult; Behavior; Biological; Breast; Cancer Control; Cancer Patient; Characteristics; Clinical; Clinical Oncology; Clinical Research; Clinical Trials; Clinical Trials Cooperative Group; Collaborations; Communities; Community Clinical Oncology Program; Consensus; DNA; Data; Data Analyses; Data Collection; Discipline; Disease; Disease Resistance; Drug Combinations; Elderly; Electronic Health Record; Enrollment; Evaluation; Funding; Genitourinary system; Hematologic Neoplasms; Infrastructure; Lead; Leadership; Malignant Neoplasms; Medidata; Methods; Mission; Molecular; Molecular Analysis; National Clinical Trials Network; Neuraxis; New Agents; Pathogenesis; Patient-Focused Outcomes; Patients; Prevention strategy; Prevention trial; Principal Investigator; Process; Recording of previous events; Regimen; Reporting; Research; Research Design; Research Personnel; Resistance; Resources; Role; Scientist; Special Populations Research; Testing; Translational Research; Underrepresented Minority; Validation; Variant; Vision; Work; base; cancer clinical trial; cancer prevention; cancer therapy; clinical practice; community setting; control trial; data sharing; design; effective therapy; experience; gastrointestinal; improved; innovation; member; multidisciplinary; multimodality; novel strategies; oncology; operation; patient engagement; prevent; programs; prospective; rare cancer; respiratory; response; therapy resistant; treatment trial; tumor

PROJECT SUMMARY The Alliance is an experienced multi-institutional cancer clinical trials group that has been reorganized in response to the IOM consensus report and NCI directives for cooperative group reorganization. Alliance provides a comprehensive and highly efficient clinical trials infrastructure, access to experienced collaborators across all disciplines of oncology clinical trials research, and a diverse portfolio of trials for patients with breast, gastrointestinal, genitourinary, respiratory, central nervous system, hematological malignancies, and selected rare tumors. Particular strengths of the Alliance include the long-standing tradition of collaborative research of the legacy members, including many who have participated in cooperative group research since its inception in 1955. The Mission of the Alliance for Clinical Trials in Oncology is to reduce the impact of cancer by: – Conducting high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network; – Furthering our understanding of the biological basis of the cancer process and its treatment; from discovery, to validation, to clinical practice; – Providing a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings.

项目摘要 该联盟是一个经验丰富的多机构癌症临床试验组，已重组， 对国际移徙组织共识报告和国家合作社协会关于合作社重组的指示的回应。联盟 提供全面、高效的临床试验基础设施， 肿瘤临床试验研究的所有学科，以及针对乳腺癌患者的多样化试验组合， 胃肠道、泌尿生殖系统、呼吸系统、中枢神经系统、血液系统恶性肿瘤和选定的 罕见肿瘤该联盟的特别优势包括长期以来的合作研究传统， 传统的成员，包括许多谁参加了合作小组的研究，因为它成立以来， 1955. 肿瘤临床试验联盟的使命是通过以下方式减少癌症的影响： - 开展高质量的多学科癌症控制、预防和治疗试验， 综合研究网络; - 促进我们对癌症过程及其治疗的生物学基础的理解; 发现、验证、临床实践; - 为创新的临床和转化研究提供科学和运营基础设施， 学术和社区环境。